Tenax Therapeutics (Formerly Known As Oxygen Biotherapeutics, Inc.)
3189 Airway Avenue, Building C
Costa Mesa
California
92626
United States
Tel: 800-809-6054
Fax: 714-427-6361
Website: http://www.oxybiomed.com/
288 articles about Tenax Therapeutics (Formerly Known As Oxygen Biotherapeutics, Inc.)
-
Tenax Therapeutics To Discuss Second Quarter 2016 Financial Results And Provide Business Update
8/4/2016
-
Tenax Therapeutics Announces First Quarter 2016 Financial Results And Provides Corporate Update
5/19/2016
-
Tenax Therapeutics To Discuss First Quarter 2016 Financial Results And Provide Business Update
5/10/2016
-
Tenax Therapeutics Announces 2015 Transitional Report And Provides Corporate Update
3/16/2016
-
Tenax Therapeutics To Provide 2015 Transitional Report And Business Update
3/10/2016
-
Tenax Therapeutics To Present At Cowen and Company 36th Annual Health Care Conference
3/2/2016
-
Tenax Therapeutics To Present At Leerink Partners 5th Annual Global Healthcare Conference
2/4/2016
-
Tenax Therapeutics Provides Update Of Phase 3 LEVO-CTS Trial For LCOS
2/2/2016
-
Tenax Therapeutics Provides Update Of Phase III LEVO-CTS Trial For LCOS
2/1/2016
-
Tenax Therapeutics Provides Update Of Phase 3 LEVO-CTS Trial For LCOS
2/1/2016
-
Tenax Therapeutics Highlights Completion Of Enrollment For LeoPARDS Trial By Imperial College London
12/22/2015
-
Tenax Therapeutics Announces Second Quarter Fiscal Year 2016 Financial Results
12/15/2015
-
Tenax Therapeutics To Provide Corporate Update And Discuss Second Quarter Fiscal Year 2016 Financial Results On December 15, 2015
12/9/2015
-
Tenax Therapeutics Provides Clinical Update For Lead Candidate Levosimendan
10/8/2015
-
Tenax Therapeutics To Present At Ladenburg Thalmann 2015 Healthcare Conference
9/22/2015
-
Tenax Therapeutics Announces First Quarter Fiscal Year 2016 Financial Results
9/14/2015
-
Tenax Therapeutics Partners With Sepsis Alliance To Raise Awareness Of Sepsis And Septic Shock
9/10/2015
-
Tenax Therapeutics To Provide Corporate Update And Discuss First Quarter Fiscal Year 2016 Financial Results On September 14, 2015
9/8/2015
-
Tenax Therapeutics Announces Nomination Of James Mitchum To Board Of Directors
8/18/2015
-
Tenax Therapeutics To Present At 2015 Wedbush PacGrow Healthcare Conference
8/5/2015